AustralianSuper Pty Ltd Trims Stake in CVS Health Corporation $CVS

AustralianSuper Pty Ltd trimmed its position in CVS Health Corporation (NYSE:CVS) by 71.0% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 200,676 shares of the pharmacy operator’s stock after selling 492,309 shares during the quarter. AustralianSuper Pty Ltd’s holdings in CVS Health were worth $15,129,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CVS. Avion Wealth lifted its stake in CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 189 shares during the period. Harbor Capital Advisors Inc. raised its holdings in shares of CVS Health by 72.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares in the last quarter. Corundum Trust Company INC purchased a new stake in shares of CVS Health in the 3rd quarter worth approximately $29,000. Harbor Asset Planning Inc. bought a new position in shares of CVS Health during the second quarter valued at approximately $30,000. Finally, Front Row Advisors LLC increased its holdings in CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 371 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on CVS shares. Mizuho lifted their price target on CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Barclays raised their price objective on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, December 10th. Wolfe Research increased their price target on shares of CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, December 8th. Wells Fargo & Company cut their price objective on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a research report on Thursday, November 13th. Finally, JPMorgan Chase & Co. increased their target price on shares of CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research report on Wednesday, December 17th. Nineteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $94.82.

CVS Health Stock Up 0.4%

CVS stock opened at $74.33 on Friday. The stock has a market capitalization of $94.35 billion, a PE ratio of 195.61, a price-to-earnings-growth ratio of 0.68 and a beta of 0.48. CVS Health Corporation has a 52 week low of $53.36 and a 52 week high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The firm has a 50 day moving average of $78.97 and a 200 day moving average of $75.01.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same period in the previous year, the firm posted $1.09 earnings per share. The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. Sell-side analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.6%. The ex-dividend date is Thursday, January 22nd. CVS Health’s payout ratio is presently 700.00%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.